Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9530210rdf:typepubmed:Citationlld:pubmed
pubmed-article:9530210lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:9530210lifeskim:mentionsumls-concept:C0225828lld:lifeskim
pubmed-article:9530210lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:9530210lifeskim:mentionsumls-concept:C0001047lld:lifeskim
pubmed-article:9530210lifeskim:mentionsumls-concept:C0018850lld:lifeskim
pubmed-article:9530210lifeskim:mentionsumls-concept:C0243043lld:lifeskim
pubmed-article:9530210lifeskim:mentionsumls-concept:C0242184lld:lifeskim
pubmed-article:9530210lifeskim:mentionsumls-concept:C0332161lld:lifeskim
pubmed-article:9530210lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:9530210pubmed:issue3 Pt 2lld:pubmed
pubmed-article:9530210pubmed:dateCreated1998-4-14lld:pubmed
pubmed-article:9530210pubmed:abstractTextIncreased synthesis of stress proteins may enhance myocardial viability during periods of low oxygen delivery. Our purpose was to determine if the oxidative stress protein heme oxygenase-1 [heat stress protein 32 (HSP 32)] was induced in hypoxic cardiomyocytes and whether this induction might be mediated by a redox-sensitive mechanism. Primary rat neonatal cardiomyocytes, cultured to express a tissuelike phenotype, responded to 12 h of hypoxia (< 0.5% ambient oxygen) with an approximately fivefold (range 3- to 7.5-fold; P < 0.05) increase in HSP 32 mRNA and a threefold (P < 0.05) increase in HSP 32 protein content. Exposure to 80 microM H2O2 for 3 h increased HSP 32 mRNA content to a similar extent. Expression of heme oxygenase-2 mRNA was unaffected by H2O2 or hypoxic treatments. Inclusion of 20 mM N-acetyl-L-cysteine in the medium during hypoxia reduced the increase in HSP 32 mRNA and protein expression by 25.50% compared with hypoxia alone. The data suggest that induction of HSP 32 protein may lead to an improved antioxidant defense in cardiomyocytes during hypoxia and that a redox-sensitive pathway mediates at least a portion of the hypoxic induction of the HSP 32 gene.lld:pubmed
pubmed-article:9530210pubmed:languageenglld:pubmed
pubmed-article:9530210pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530210pubmed:citationSubsetIMlld:pubmed
pubmed-article:9530210pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530210pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530210pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530210pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530210pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530210pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530210pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530210pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530210pubmed:statusMEDLINElld:pubmed
pubmed-article:9530210pubmed:monthMarlld:pubmed
pubmed-article:9530210pubmed:issn0002-9513lld:pubmed
pubmed-article:9530210pubmed:authorpubmed-author:EssigD ADAlld:pubmed
pubmed-article:9530210pubmed:authorpubmed-author:BorgerD RDRlld:pubmed
pubmed-article:9530210pubmed:issnTypePrintlld:pubmed
pubmed-article:9530210pubmed:volume274lld:pubmed
pubmed-article:9530210pubmed:ownerNLMlld:pubmed
pubmed-article:9530210pubmed:authorsCompleteYlld:pubmed
pubmed-article:9530210pubmed:paginationH965-73lld:pubmed
pubmed-article:9530210pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:9530210pubmed:meshHeadingpubmed-meshheading:9530210-...lld:pubmed
pubmed-article:9530210pubmed:meshHeadingpubmed-meshheading:9530210-...lld:pubmed
pubmed-article:9530210pubmed:meshHeadingpubmed-meshheading:9530210-...lld:pubmed
pubmed-article:9530210pubmed:meshHeadingpubmed-meshheading:9530210-...lld:pubmed
pubmed-article:9530210pubmed:meshHeadingpubmed-meshheading:9530210-...lld:pubmed
pubmed-article:9530210pubmed:meshHeadingpubmed-meshheading:9530210-...lld:pubmed
pubmed-article:9530210pubmed:meshHeadingpubmed-meshheading:9530210-...lld:pubmed
pubmed-article:9530210pubmed:meshHeadingpubmed-meshheading:9530210-...lld:pubmed
pubmed-article:9530210pubmed:meshHeadingpubmed-meshheading:9530210-...lld:pubmed
pubmed-article:9530210pubmed:meshHeadingpubmed-meshheading:9530210-...lld:pubmed
pubmed-article:9530210pubmed:meshHeadingpubmed-meshheading:9530210-...lld:pubmed
pubmed-article:9530210pubmed:meshHeadingpubmed-meshheading:9530210-...lld:pubmed
pubmed-article:9530210pubmed:meshHeadingpubmed-meshheading:9530210-...lld:pubmed
pubmed-article:9530210pubmed:meshHeadingpubmed-meshheading:9530210-...lld:pubmed
pubmed-article:9530210pubmed:year1998lld:pubmed
pubmed-article:9530210pubmed:articleTitleInduction of HSP 32 gene in hypoxic cardiomyocytes is attenuated by treatment with N-acetyl-L-cysteine.lld:pubmed
pubmed-article:9530210pubmed:affiliationDepartment of Exercise Science, University of South Carolina, Columbia 29208, USA.lld:pubmed
pubmed-article:9530210pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9530210lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9530210lld:pubmed